References
- Suzuki H, Kanno Y. Efficacy of can desartan on outcome in Saitama trial (E-COST) group: effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res 2005;28:307–14.
- Yagil Y, Yagil C. The search for the genetic basis of hypertension. Curr Opin Nephrol Hypertens 2005;14:141–7.
- Padma G, Bhupatiraju C, Srinivas B, et al. High risk for essential hypertension in males conferred by g.15241A4G polymorphism in intron 3 of AGT gene. Clin Exp Hypertens 2013;35:108–11.
- Zordoky BN, El-Kadi AO. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 2010;125:446–63.
- Elbekai RH, El-Kadi AO. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 2006;112:564–87.
- Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002;82:131–85.
- Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure: evidence from the health survey for England. hypertension 2001;37(2):187–93.
- Thuy AB, Blizzard L, Schmidt MD, et al. The association between smoking and hypertension in a population-based sample of Vietnamese men. J Hypertens 2010;28(2):245–50.
- Virdis A, Giannarelli C, Neves MF, et al. Cigarette smoking and hypertension. Curr Pharm Des 2010;16(23):2518–25.
- Yang H, Fu Z, Ma Y, et al. CYP4A11 gene T8590C polymorphism is associated with essential hypertension in the male western Chinese Han population. Clin Exp Hypertens 2014;36(6): 398–403.
- Gainer JV, Bellamine A, Dawson EP, et al. Functional variant of CYP4A11 20-Hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005;111(1):63–9.
- Fu Z, Nakayama T, Sato N, et al. A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. J Hypertens 2008;26:453–61.
- World Health Organization. International society of hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151–83.
- Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 2007;80(6):1125–37.
- Yan H-C, Liu J-H, Li J, et al. Association between the CYP4A11 T8590C variant and essential hypertension: new data from han Chinese and a meta-analysis. PLoS One 2013;8(11):e80072.
- Fu Z, Ma Y, Xie X, et al. A novel polymorphism of the CYP4A11 Gene is associated with coronary artery disease. Clin Appl Thromb Hemost 2013;19(1):60–5.
- Mayer B, Lieb W, Götz A, et al. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J Hypertens 2006;24(10):1965–70.
- Muthalif MM, Parmentier JH, Benter IF, et al. Ras/mitogen-activated protein kinase mediates norepinephrine-induced phospholipase D activation in rabbit aortic smooth muscle cells by a phosphorylation-dependent mechanism. J Pharmacol Exp Ther 2000;293:268–74.
- Uddin MR, Muthalif MM, Karzoun NA, et al. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 1998;31:242–7.
- Yousif MH, Benter IF. Role of cytochrome P450 metabolites of arachidonic acid in regulation of corporal smooth muscle tone in diabetic and older rats. Vascul Pharmacol 2007;47:281–7.
- Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2þ)-activated Kþ channel in renal arterioles. Am J Physiol 1996; 270(1 Pt 2):R228–37.
- Capdevila JH, Falck JR, Imig JD. Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. Kidney Int 2007;72:683–9.